The primary action of GLP-1 receptor agonists is to increase insulin production in response to high blood sugar levels
Some peptides reconstitute better in saline than plain water
Automated Alerts: Patients can sign-up to receive automated email alerts, delivered when a GLP-1 drug is reported in supply in their area or when the status of a GLP-1 drug changes on the FDA's Drug Shortage List
Additionally, the secondary bile acids 3-oxoLCA and isoLCA function as TGR5 agonists that suppress the differentiation of Th17 cells in vitro through two mechanisms: (1) directly inhibiting the expression of RORt, and (2) promoting the polarization of M2 macrophages, which indirectly inhibits the development of Th17 cells (119)
Key Takeaways Microdosing could theoretically reduce peak-to-trough ratios by 28-38%, potentially minimizing side effects Successful precedents exist with insulin and growth hormone therapies using similar principles Mathematical models suggest maintained efficacy (~75-100%) with appropriate dose adjustments No clinical trials have validated microdosing for GLP-1 agonists - all evidence is theoretical or anecdotal 55% of microdosers make decisions without physician consultation, raising safety concerns What Is Retatrutide Microdosing
Kumar agrees, adding, "It's important to understand that your body already produces GLP-1 naturally
